SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 79.780.0%Dec 31 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (2639)10/15/2009 9:17:55 AM
From: Jibacoa   of 3722
 
ACOR is up 52.09% on premarket trading.

It announced today that an FDA committee voted 12 to 1 that in favor of Fampridine-SR 10 mg BID based on data that demonstrated evidence of effectiveness treating patients with MS, helping to improve walking and also voted 10 to 2 with 1 abstention, that it is clinically meaningful and can be safe for use.<g>

The stock is closing its Oct 9 DG trading at $25.13 in premarket

bigcharts.marketwatch.com

The ACTAY is $27.63
The stock needs to close above the $27 level in order to get off from its longer term DT coming from the Aug 2008 H at $35.65

bigcharts.marketwatch.com

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext